Potential of CETP inhibitors in patients with AA genotype must await outcome trial
ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy